Skip to content
Screener

Moderna MRNA Other revenue — Total Revenue

Other product segments

Stand-ready manufacturing revenue
$32M+167%
Collaboration Arrangement, Including Arrangements With Affiliate
$5M+400%
Grant revenue
$0-100%
Licensing and royalty revenue
$0-100%

Similar metrics at other companies

ImmunityBio, Inc. logo
IBRXOther revenues — Total Revenue
$39K+388%
Gemini Space Station logo
GEMIOther revenue — Total Revenue
$1.69M+726%
Life Time Group Holdings logo
LTHOther revenue — Total Revenue
$28.59M+11.7%
Sirius XM logo
SIRIOther revenue — Total Revenue
$68M-11.7%
GeneDx Holdings logo
WGSOther revenue — Total Revenue
$955K-29.6%
Snap logo
SNAPOther revenue — Total Revenue
$316.47M+84.7%

Other financials

Income statement

See full
Revenue$145.0M+2.1%
Gross profit$52.0M+126%
Operating income-$815.0M+10.1%
Net income-$782.0M+5.2%
EPS (diluted)-$1.97+7.5%

Balance sheet

See full
Cash & equivalents$1.7B+34.5%
Total debt$1.2B+60.8%
Total equity$6.8B-28.1%
Total assets$11.0B-8.7%

Cash flow

See full
Operating cash flow-$526.0M+42.8%
CapEx$37.0M+1,133%
Free cash flow-$563.0M+38.9%

Valuation

See full
Market cap$22.46B+116%
Enterprise value$21.97B+122%
P/S10.1×+6.7×

Profitability

See full
Gross margin23.4%-29.1pp
Operating margin-149%+99.9pp
Net margin-141.4%+141pp
FCF margin-132.4%—

Returns & leverage

See full
Return on equity-39%+28.0pp
Debt / equity0.2×+0.1×
Current ratio2.3×-1.6×

Where this comes from

Reported directly by Moderna in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Moderna’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 4:10 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001682852-26-000060
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Revenue:
Net product sales$352$86
Other revenue3722
Total revenue389108
Operating expenses:
Cost of sales95590
Research and development649856
Selling, general and administrative173212

Item 1. Financial Statements (Unaudited)

FAQ

What is Moderna's other revenue — total revenue?
Moderna (MRNA) reported other revenue — total revenue of $37M in Q1 2026.
How has Moderna's other revenue — total revenue changed year-over-year?
Moderna's other revenue — total revenue increased by 68.2% year-over-year, from $22M to $37M.
What is the long-term trend for Moderna's other revenue — total revenue?
Over 4 years (2021 to 2025), Moderna's other revenue — total revenue has grown at a -35.7% compound annual growth rate (CAGR), from $796M to $136M.
What does other revenue — total revenue mean?
This represents the total gross revenue generated from secondary business activities or non-core product lines within the company's reporting segments. It captures income streams that fall outside the primary commercial product portfolio, often including collaborative research, grant funding, or ancillary service agreements.

Ask your AI about Moderna's other revenue — total revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude